These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1720080)

  • 1. Role of iron and proteins of iron metabolism in cell growth. Potential for manipulations of cellular iron metabolism in modulating cell proliferation.
    Cazzola M; Bergamaschi G; Dezza L; Ponchio L; Rosti V; Zappone E; Ascari E
    Curr Stud Hematol Blood Transfus; 1991; (58):153-7. PubMed ID: 1720080
    [No Abstract]   [Full Text] [Related]  

  • 2. The in vitro response of human tumour cells to desferrioxamine is growth medium dependent.
    Voest EE; Rooth H; Neijt JP; van Asbeck BS; Marx JJ
    Cell Prolif; 1993 Jan; 26(1):77-88. PubMed ID: 8439591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.
    Brodie C; Siriwardana G; Lucas J; Schleicher R; Terada N; Szepesi A; Gelfand E; Seligman P
    Cancer Res; 1993 Sep; 53(17):3968-75. PubMed ID: 8358725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The iron metabolism of neoplastic cells: alterations that facilitate proliferation?
    Kwok JC; Richardson DR
    Crit Rev Oncol Hematol; 2002 Apr; 42(1):65-78. PubMed ID: 11923069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scara5 is a ferritin receptor mediating non-transferrin iron delivery.
    Li JY; Paragas N; Ned RM; Qiu A; Viltard M; Leete T; Drexler IR; Chen X; Sanna-Cherchi S; Mohammed F; Williams D; Lin CS; Schmidt-Ott KM; Andrews NC; Barasch J
    Dev Cell; 2009 Jan; 16(1):35-46. PubMed ID: 19154717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukaemic cells.
    Bomford A; Isaac J; Roberts S; Edwards A; Young S; Williams R
    Biochem J; 1986 May; 236(1):243-9. PubMed ID: 3790074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transferrin-indium on cellular proliferation of a human leukemia cell line.
    Moran PL; Seligman PA
    Cancer Res; 1989 Aug; 49(15):4237-41. PubMed ID: 2743310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the membrane receptor for human H-ferritin.
    Fargion S; Fracanzani AL; Cislaghi V; Levi S; Cappellini MD; Fiorelli G
    Curr Stud Hematol Blood Transfus; 1991; (58):164-70. PubMed ID: 1659511
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of hematopoietic tumor growth by combined treatment with deferoxamine and an IgG monoclonal antibody against the transferrin receptor: evidence for a threshold model of iron deprivation toxicity.
    Kemp JD; Thorson JA; Stewart BC; Naumann PW
    Cancer Res; 1992 Aug; 52(15):4144-8. PubMed ID: 1638529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle effects of iron depletion on T-47D human breast cancer cells.
    Reddel RR; Hedley DW; Sutherland RL
    Exp Cell Res; 1985 Dec; 161(2):277-84. PubMed ID: 2998833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of expression of ferritin H-chain and transferrin receptor by protoporphyrin IX.
    Coccia EM; Perrotti E; Stellacci E; Orsatti R; Del Russo N; Marziali G; Testa U; Battistini A
    Eur J Biochem; 1997 Dec; 250(3):764-72. PubMed ID: 9461300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies.
    Taetle R; Castagnola J; Mendelsohn J
    Cancer Res; 1986 Apr; 46(4 Pt 1):1759-63. PubMed ID: 3004704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of transferrin receptors, iron content and isoferritin profile in normal and malignant human breast cell lines.
    Shterman N; Kupfer B; Moroz C
    Pathobiology; 1991; 59(1):19-25. PubMed ID: 2043266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the transferrin receptor in K562 erythroleukemia cells.
    Cudkowicz A; Klausner RD; Bridges KR
    Prog Clin Biol Res; 1984; 165():509-19. PubMed ID: 6095315
    [No Abstract]   [Full Text] [Related]  

  • 15. Iron metabolism.
    Finch CA; Huebers HA
    Clin Physiol Biochem; 1986; 4(1):5-10. PubMed ID: 3006969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin and ferritin endocytosis and recycling in guinea-pig reticulocytes.
    Blight GD; Morgan EH
    Biochim Biophys Acta; 1987 Jun; 929(1):18-24. PubMed ID: 3036246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron, iron-binding proteins and immune system cells.
    De Sousa M; Breedvelt F; Dynesius-Trentham R; Trentham D; Lum J
    Ann N Y Acad Sci; 1988; 526():310-22. PubMed ID: 3291685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor.
    Kemp JD; Smith KM; Kanner LJ; Gomez F; Thorson JA; Naumann PW
    Blood; 1990 Sep; 76(5):991-5. PubMed ID: 2393721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and function of transferrin receptors and their relationship to cell growth.
    Trowbridge IS; Shackelford DA
    Biochem Soc Symp; 1986; 51():117-29. PubMed ID: 3545211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH).
    Forsbeck K; Bjelkenkrantz K; Nilsson K
    Scand J Haematol; 1986 Nov; 37(5):429-37. PubMed ID: 3810041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.